ArticleJournal of oncology2022

A 5-Pathway Signature Predicts Prognosis Based on Immune-Derived lncRNAs in Patients with Breast Cancer.

Bo Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.